Government
Penny Stocks Buying Guide For 2022, 3 Tips and Tricks
Wondering how to trade penny stocks in 2022? Here are three tips and tricks to do just that
The post Penny Stocks Buying Guide For 2022, 3 Tips and Tricks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Tips and Tricks For Buying Penny Stocks in 2022
Understanding how to buy penny stocks is one of the most crucial parts of investing in 2022. While it can seem difficult given the sheer number of factors impacting the stock market right now, it isn’t impossible. Because of the countless penny stocks to choose from, understanding which have value can mean the difference between profits and losses.
And, because penny stocks are so speculative, knowing what is going on in the stock market is crucial. Right now, there are three main topics that investors need to understand. First, traders need to know what is going on in 2022 that will affect their portfolio. Second, investors need to have a proper strategy that can evolve with new trends as time goes on. This is extremely important as the market is changing faster than it has in many years.
[Read More] Best Penny Stocks For Your January Watchlist, 3 to Check Out
Lastly, traders need to keep track of market trends in 2022. These three topics will give your portfolio the best chance of succeeding this year. And with the virus continuing to wreak havoc in world markets, having a competitive edge is highly beneficial. So, with all of that in mind, let’s take a look at an in-depth view of what investors should know this year.
3 Things Penny Stocks Investors Should Know This Year
- What to Watch With Penny Stocks in 2022
- How to Trade Penny Stocks in 2022
- Which Industries Are Investors Watching Right Now?
What to Watch With Penny Stocks in 2022
In 2022, there are many things for investors to keep track of. We have the pandemic at the top of the list and its resulting impact. In the past two months, we’ve seen a massive rise in the number of virus cases due to the newest variant. While many believe that case numbers could begin dropping, this is one of the most significant factors for those who invest in penny stocks to consider.
In line with this, we have to understand that the pandemic has led to major inflation, less-than-stellar jobs reports, and sizable shortages of goods globally. So, all of this should be considered when coming up with a trading strategy.
In addition, investors should understand that there is a large amount of volatility in the stock market due to all of this. While this is not something to be fearful of, it should be kept in mind. So, while this is not everything that will occur in 2022, these factors should help put you on the right track.
How to Trade Penny Stocks in 2022
With a New Year in full effect, investors are working hard to bring their trading strategies up to par. Although it can seem complicated, there are two main strategies to work from. On the one hand, we have the most popular method of trading penny stocks; swing trading. This involves holding stocks for a short time frame, hoping for large move in price during that period. Swing trading is extremely popular with penny stocks due to the rate they tend to move. But, with swing trading comes the potential to lose money just as quickly as it is made.

So, understanding exactly what movement you’re looking for and setting portfolio goals can significantly help to mitigate this risk. On the other hand, we have long-term trading. This is relatively self-explanatory and is somewhat less popular with penny stocks. However, because penny stocks can escape the $5 threshold, many choose to find and hold them long-term.
[Read More] Penny Stocks, Pelosi, & 3 Government Reps Buying Cheap Stocks Now
This can be riskier as there is a lot of movement that occurs in the meantime. But, if you are more or less confident in the direction of a given penny stock, it could be worth looking into. So, there is a lot to consider when it comes to trading penny stocks in 2022. But, with the right strategy on hand, it can be much easier than previously imagined.
Which Industries Are Investors Watching Right Now?
Right now, there are three industries that investors are watching in particular. First, we have biotech penny stocks. This makes sense as the pandemic has highlighted these companies as having a prominent role in the industry. While not all biotech stocks have a place in treating the latest virus strain, there are many with hands in the pandemic.

Second, we have tech penny stocks. With at-home work and education occurring globally, many investors have turned to tech stocks as a way to benefit in the long term. It is essential to consider what the company does and whether it will gain or lose in the next few weeks or months.
Thirdly, we have energy stocks. This is a key industry as energy is directly and inversely impacted by the number of cases of Covid going on in the world. When case numbers jump, we tend to see a fall in the price of energy as demand is lower. And, this works in the opposite direction as well. So, with these three industries in mind, which penny stocks are you watching in 2022?
Are Penny Stocks Worth Buying This Year?
If you’re looking for the best penny stocks to buy this year, there are plenty to choose from. While it can be difficult at times, understanding precisely what is going on in the market and how to take advantage will be an asset. A consistent factor on how penny stocks trade is the latest virus variant.
[Read More] Best Penny Stocks to Buy Now? 3 Trump Stocks to Watch in January
While many believe that the pandemic could begin to lessen in severity in the coming months, we do expect volatility to continue in the meantime. For this reason, keeping a well-thought-out trading strategy on hand and utilizing it will help to increase your chances of profitability.
And, because penny stocks are so speculative, understanding exactly what is going on in the market will always be a major benefit. In addition, we have to consider current and future trends and how they will impact the stocks on your watchlist. So, with that in mind, do you think that penny stocks are worth buying in 2022 or not?
Want To Read More About Trending Penny Stocks Right Now? Check Out Some Of These Articles:
- Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today
- 5 Cryptocurrencies Up Big In 2022 Trading Like Penny Stocks
- 3 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
- Best Penny Stocks For Your January Watchlist, 3 to Check Out
- Are These 3 Penny Stocks on Your January Watchlist?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!
The post Penny Stocks Buying Guide For 2022, 3 Tips and Tricks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
stocks pandemic penny stocks trumpSpread & Containment
Repeated COVID-19 Vaccination Weakens Immune System: Study
Repeated COVID-19 Vaccination Weakens Immune System: Study
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
Repeated COVID-19…

Authored by Zachary Stieber via The Epoch Times (emphasis ours),
Repeated COVID-19 vaccination weakens the immune system, potentially making people susceptible to life-threatening conditions such as cancer, according to a new study.
Multiple doses of the Pfizer or Moderna COVID-19 vaccines lead to higher levels of antibodies called IgG4, which can provide a protective effect. But a growing body of evidence indicates that the “abnormally high levels” of the immunoglobulin subclass actually make the immune system more susceptible to the COVID-19 spike protein in the vaccines, researchers said in the paper.
They pointed to experiments performed on mice that found multiple boosters on top of the initial COVID-19 vaccination “significantly decreased” protection against both the Delta and Omicron virus variants and testing that found a spike in IgG4 levels after repeat Pfizer vaccination, suggesting immune exhaustion.
Studies have detected higher levels of IgG4 in people who died with COVID-19 when compared to those who recovered and linked the levels with another known determinant of COVID-19-related mortality, the researchers also noted.
A review of the literature also showed that vaccines against HIV, malaria, and pertussis also induce the production of IgG4.
“In sum, COVID-19 epidemiological studies cited in our work plus the failure of HIV, Malaria, and Pertussis vaccines constitute irrefutable evidence demonstrating that an increase in IgG4 levels impairs immune responses,” Alberto Rubio Casillas, a researcher with the biology laboratory at the University of Guadalajara in Mexico and one of the authors of the new paper, told The Epoch Times via email.
The paper was published by the journal Vaccines in May.
Pfizer and Moderna officials didn’t respond to requests for comment.
Both companies utilize messenger RNA (mRNA) technology in their vaccines.
Dr. Robert Malone, who helped invent the technology, said the paper illustrates why he’s been warning about the negative effects of repeated vaccination.
“I warned that more jabs can result in what’s called high zone tolerance, of which the switch to IgG4 is one of the mechanisms. And now we have data that clearly demonstrate that’s occurring in the case of this as well as some other vaccines,” Malone, who wasn’t involved with the study, told The Epoch Times.
“So it’s basically validating that this rush to administer and re-administer without having solid data to back those decisions was highly counterproductive and appears to have resulted in a cohort of people that are actually more susceptible to the disease.”
Possible Problems
The weakened immune systems brought about by repeated vaccination could lead to serious problems, including cancer, the researchers said.
Read more here...
Spread & Containment
Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction
Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction
Authored by Jessie Zhang via Thje Epoch…

Authored by Jessie Zhang via Thje Epoch Times (emphasis ours),
An Australian and Swedish investigation has found that among the hundreds of COVID-19 research papers that have been withdrawn, a retracted study linking the drug hydroxychloroquine to increased mortality was the most cited paper.
With 1,360 citations at the time of data extraction, researchers in the field were still referring to the paper “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” long after it was retracted.
Authors of the analysis involving the University of Wollongong, Linköping University, and Western Sydney Local Health District wrote (pdf) that “most researchers who cite retracted research do not identify that the paper is retracted, even when submitting long after the paper has been withdrawn.”
“This has serious implications for the reliability of published research and the academic literature, which need to be addressed,” they said.
“Retraction is the final safeguard against academic error and misconduct, and thus a cornerstone of the entire process of knowledge generation.”
Scientists Question Findings
Over 100 medical professionals wrote an open letter, raising ten major issues with the paper.
These included the fact that there was “no ethics review” and “unusually small reported variances in baseline variables, interventions and outcomes,” as well as “no mention of the countries or hospitals that contributed to the data source and no acknowledgments to their contributions.”

Other concerns were that the average daily doses of hydroxychloroquine were higher than the FDA-recommended amounts, which would present skewed results.
They also found that the data that was reportedly from Australian patients did not seem to match data from the Australian government.
Eventually, the study led the World Health Organization to temporarily suspend the trial of hydroxychloroquine on COVID-19 patients and to the UK regulatory body, MHRA, requesting the temporary pause of recruitment into all hydroxychloroquine trials in the UK.
France also changed its national recommendation of the drug in COVID-19 treatments and halted all trials.
Currently, a total of 337 research papers on COVID-19 have been retracted, according to Retraction Watch.
Further retractions are expected as the investigation of proceeds.
Government
Biden Signs Debt Ceiling Bill, Ending Monthslong Political Battle
Biden Signs Debt Ceiling Bill, Ending Monthslong Political Battle
Authored by Lawrence Wilson via The Epoch Times,
President Joe Biden signed…

Authored by Lawrence Wilson via The Epoch Times,
President Joe Biden signed the Fiscal Responsibility Act on Saturday, suspending the debt ceiling for 19 months and bringing a monthslong political battle to a close.
The compromise legislation negotiated by Biden and House Speaker Kevin McCarthy (R-Calif.) passed both houses of Congress with bipartisan support this week, averting a potential default on the nation’s financial obligations.
“Passing this budget agreement was critical. The stakes could not have been higher,” Biden said in a Friday evening address to the nation from the Oval Office.
Congressional leaders in both parties, eager to avoid financial disaster, endorsed the bill.
McCarthy referred to the legislation in historic terms, calling it the biggest spending cut ever enacted by Congress. Senate Majority Leader Chuck Schumer (D-N.Y.) said, “We’ve saved the country from the scourge of default,” after the bill passed the Senate on June 1.
House Minority Leader Hakeem Jeffries (D-N.Y.) and Senate Minority Leader Mitch McConnell (R-Ky.) both supported the bill.
Biden vs. McCarthy
The president’s signature ends a monthslong cold war with McCarthy over terms for raising the nation’s $31.4 trillion debt ceiling.
The Financial Responsibility Act suspends the debt ceiling until Jan. 1, 2025, cuts non-defense discretionary spending slightly in 2024, and limits discretionary spending growth to 1 percent in 2025.
The agreement also contains permitting reforms for oil and gas drilling, changes to work requirements for some social welfare programs, and clawbacks of $20 billion in IRS funding and $30 billion in unspent COVID-19 relief funds, among other provisions.
President Joe Biden hosts debt limit talks with House Speaker Kevin McCarthy (R-Calif.) and other congressional leaders in the Oval Office at the White House on May 9, 2023. (Kevin Lamarque/Reuters)
In the absence of congressional action to allow additional borrowing, the United States would have lacked the ready cash to pay all of its bills on June 5, according to Treasury Secretary Janet Yellen.
Yellen announced in January that the country was in danger of reaching its limit.
McCarthy then said Congress would not increase the limit without an agreement from the White House to cut spending. Biden said he would not negotiate over lifting the limit because that would put the full faith and credit of the United States at risk.
The impasse was broken in late April when the House passed the Limit, Save, Grow Act, authorizing a $1.5 trillion increase in borrowing along with spending cuts and other measures favored by Republicans.
Biden then agreed to negotiate with McCarthy, resulting in the Fiscal Responsibility Act.
Opposition
A vocal minority of lawmakers in both parties opposed the bill.
Some Republicans believed the agreement conceded too much to Democrats. Rep. Chip Roy (R-Texas) nearly blocked the bill in committee, but it cleared by a single vote.
Some Democrats opposed the agreement because it cuts discretionary spending and changes work requirements for the Supplemental Nutrition Assistance Program (SNAP). They said those provisions would hurt working Americans and those in need.
House Rules Committee member Rep. Chip Roy (R-Texas) speaks at the Capitol on Jan. 30. (Win McNamee/Getty Images)
A group of Senate Republicans led by Lindsey Graham (R-N.C.) and Susan Collins (R-Maine) initially opposed the bill due to concerns about the level of defense spending. They were brought on board by assurances from Schumer and McConnell that emergency defense appropriations could be added later if needed.
The bill passed the House by a vote of 314 to 117 on May 31. Forty-six Democrats and 71 Republicans voted no.
The Senate passed the measure 63 to 36 the next day. Four Democrats, one Independent, and 41 Republicans voted no.
Mixed Reactions
Outside the Capitol, some observers applauded the bipartisan effort while others echoed the complaints of congressional dissenters.
“This kind of compromise is exactly how divided government should work,” Kelly Veney Darnell, interim CEO of the Bipartisan Policy Center, said in a June 2 statement.
EJ Antoni, a research fellow at The Heritage Institute, said “conservatives have little to celebrate with this deal, and much about which to complain.” According to Antoni, the bill doesn’t actually cut spending. He called it “left-wing legislation” in a statement published June 1.
Navin Nayak, counselor at the Center for American Progress, endorsed the legislation unenthusiastically, saying it was imperfect but necessary in a May 31 statement. Nayak said the Mountain Valley Pipeline, green-lighted by the bill, puts the safety of thousands at risk and the added work requirements will increase hunger in America.
Congress must now work the provisions of the Fiscal Responsibility Act into a federal budget and the dozen appropriations bills required to fund the government in the coming year.
The 2024 fiscal year begins on Oct. 1.
-
Spread & Containment4 hours ago
Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked
-
Spread & Containment7 hours ago
Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction
-
Spread & Containment14 hours ago
Mark Zuckerberg Moves to Kill a Pandemic Habit
-
Government10 hours ago
Biden Signs Debt Ceiling Bill, Ending Monthslong Political Battle
-
Uncategorized7 hours ago
Warren Buffett’s Advice on Stocks vs. Bonds
-
International15 hours ago
Complying, Not Defying: Twitter And The EU Censorship Code
-
Spread & Containment11 hours ago
Mark Zuckerberg Makes a Bold Move
-
Spread & Containment3 hours ago
Repeated COVID-19 Vaccination Weakens Immune System: Study